Mobia Medical, Inc. (NASDAQ:MOBI) Given Average Recommendation of "Moderate Buy" by Analysts

Key Points

• Analysts hold a “Moderate Buy” consensus on Mobia Medical, with five buy ratings, one hold and one sell. The average 12-month price target is $20.75, well above the stock’s $11.76 opening price.
• Mobia Medical reported quarterly revenue of $13.51 million, up 102.4% year over year, but its loss of $1.10 per share missed the consensus estimate of a $0.83 loss.
• CFO Nelson Bunker Curnes purchased 5,000 shares at an average price of $12.79, increasing his direct holdings to 366,997 shares.

Shares of Mobia Medical, Inc. (NASDAQ:MOBI - Get Free Report) have received a consensus rating of "Moderate Buy" from the seven ratings firms that are currently covering the company, MarketBeat reports. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and five have assigned a buy rating to the company. The average 12-month price objective among analysts that have issued a report on the stock in the last year is $20.75.

A number of equities research analysts have commented on MOBI shares. The Goldman Sachs Group started coverage on Mobia Medical in a report on Tuesday, June 2nd. They set a "buy" rating and a $31.00 price target on the stock. BTIG Research reiterated a "buy" rating and set a $19.00 target price on shares of Mobia Medical in a research report on Wednesday. Zacks Research upgraded Mobia Medical to a "hold" rating in a research report on Wednesday, June 3rd. Bank of America started coverage on Mobia Medical in a research note on Tuesday, June 2nd. They set a "buy" rating and a $16.00 target price on the stock. Finally, Wolfe Research began coverage on Mobia Medical in a report on Tuesday, June 2nd. They issued an "outperform" rating on the stock.

Mobia Medical Price Performance

Shares of MOBI stock opened at $11.76 on Friday. The company has a quick ratio of 5.55, a current ratio of 13.28 and a debt-to-equity ratio of 0.04. Mobia Medical has a one year low of $10.19 and a one year high of $15.29. The company's fifty day moving average price is $12.44. The company has a market cap of $391.49 million and a P/E ratio of -0.61.

Mobia Medical (NASDAQ:MOBI - Get Free Report) last issued its earnings results on Tuesday, August 11th. The company reported ($1.10) earnings per share for the quarter, missing the consensus estimate of ($0.83) by ($0.27). The company had revenue of $13.51 million for the quarter. The firm's quarterly revenue was up 102.4% compared to the same quarter last year. Equities research analysts expect that Mobia Medical will post -2.76 earnings per share for the current fiscal year.

Insider Activity

In related news, CFO Nelson Bunker Curnes acquired 5,000 shares of Mobia Medical stock in a transaction dated Tuesday, June 9th. The shares were purchased at an average price of $12.79 per share, for a total transaction of $63,950.00. Following the completion of the transaction, the chief financial officer directly owned 366,997 shares in the company, valued at approximately $4,693,891.63. This represents a 1.38% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.

Mobia Medical Company Profile

Mobia Medical Inc is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. Mobia Medical Inc is based in AUSTIN, Texas.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source